Search Ontology:
ChEBI
beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
- Term ID
- CHEBI:147248
- Synonyms
-
- 2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranose
- 2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
- GlcNAc(b1-4)Gal(b1-4)GlcNAc
- N-[(3R,4R,5S,6R)-5-[(2S,3R,4R,5R,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- Definition
- An amino trisaccharide consisting of 2-acetamido-2-deoxy-β-D-glucopyranose, β-D-galactopyranose and 2-acetamido-2-deoxy-D-glucopyranose residues joine in sequence by (1→4) glycosidic bonds.
- References
-
- glygen:G07923CD
- glytoucan:G07923CD
- kegg.glycan:G08907
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype where environments contain beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype modified by environments containing beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype affecting beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-GlcpNAc
Human Disease Model